IP Library Granted Patent US 6,951,963
Granted Patent B2
US 6,951,963 · App. 10/462,150 · Granted Oct 4, 2005

Process for preparing N-protected β-amino aldehyde compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,951,963
App. No.
10/462,150
Granted
Oct 4, 2005
Kind
B2
Abstract

The invention provides processes for preparing N-protected β-amino aldehyde compounds which are useful as synthetic intermediates for preparing glycopeptide antibiotic derivatives. The processes include cleaving a carbon-carbon double bond to form the N-protected β-amino aldehyde compound.

Claims (57)

1. A process for preparing a compound of formula I:

wherein R 1 is a 9-fluorenylmethoxycarbonyl group; and n is an integer from 7 to 11;

the process comprising cleaving the double bond of a compound of formula II:

wherein R 2 is hydrogen or C 1-12 hydrocarbyl;

wherein the step of cleaving the double bond comprises the steps of:

(a) reacting a compound of formula II with ozone to form an ozonide intermediate;

(b) reacting the ozonide intermediate from step (a) with a reducing agent to form a compound of formula I;

or the step of cleaving the double bond comprises the steps of:

(a) reacting a compound of formula II with a glycol-forming oxidizing agent to form a glycol intermediate;

(b) reacting the glycol intermediate from step (a) with a glycol-cleaving oxidizing agent to provide a compound of formula I.

2. The process according to claims 1 , wherein R 2 is hydrogen or C 1-12 alkyl.

3. The process according to claim 2 , wherein R 2 is hydrogen.

4. The process according to claim 1 , wherein n is an integer from 8 to 10.

5. The process according to claim 4 , wherein n is 9.

6. The process according to claim 1 , wherein R 2 is hydrogen; and n is 9.

7. The process according to claim 1 , wherein the step of cleaving the double bond comprises the steps of:

(a) reacting a compound of formula II with ozone to form an ozonide intermediate;

(b) reacting the ozonide intermediate from step (a) with a reducing agent to form a compound of formula I.

8. The process according to claim 7 , wherein the reducing agent is a trialkylamine.

9. The process according to claim 8 , wherein the reducing agent is triethylamine.

10. The process according to claim 1 , wherein the step of cleaving the double bond comprises the steps of:

(a) reacting a compound of formula II with a glycol-forming oxidizing agent to form a glycol intermediate:

(b) reacting the glycol intermediate from step (a) with a glycol-cleaving oxidizing agent to provide a compound of formula I.

11. The process according to claim 10 , wherein the oxidizing agent employed in step (a) and step (b) is the same and the oxidizing agent is sodium periodate and catalytic osmium tetroxide or ruthenium (IV) oxide.

12. A process for preparing a compound of formula I:

wherein R 1 is an amino-protecting group; and n is an integer from 7 to 11;

the process comprising the steps of:

(a) reacting a compound of formula III:

R 2 —CH═CH—CH 2 —NH 2   III

wherein R 2 is hydrogen or C 1-12 hydrocarbyl; with a compound of formula IV:

X—(CH 2 ) n —CH 3   IV

wherein X is a leaving group; to provide a compound of formula V:

(b) reacting the compound of formula V with an amino-protecting group reagent; to provide a compound of formula II:

(c) cleaving the double bond of the compound of formula wherein the step of cleaving the double bond comprises the steps of:

(a) reacting a compound of formula II with ozone to form ozonide intermediate;

(b) reacting the ozonide intermediate from step (a) with a reducing agent to form a compound of formula I;

or the step of cleaving the double bond comprises the steps of:

(a) reacting a compound of formula II with a glycol-forming oxidizing agent to form a glycol intermediate:

(b) reacting the glycol intermediate from step (a) with a glycol-cleaving oxidizing agent to provide a compound of formula I.

13. The process according to claim 12 , wherein R 1 is an amino-protecting group selected from the group consisting of tert-butoxycarbonyl; benzyloxycarbonyl; and 9-fluorenylmethoxycarbonyl.

14. The process according to claim 13 , wherein R 1 is a 9-fluorenylmethoxycarbonyl group.

15. The process according to claims 12 , wherein R 2 is hydrogen or C 1-12 alkyl.

16. The process according to claim 15 , wherein R 2 is hydrogen.

17. The process according to claim 12 , wherein n is an integer from 8 to 10.

18. The process according to claim 17 , wherein n is 9.

19. The process according to claim 12 , wherein X is chloro or bromo.

20. The process according to claim 19 , wherein X is bromo.

21. The process according to claim 1 , wherein R 1 is a 9-fluorenylmethoxycarbonyl group; R 2 is hydrogen; X is bromo; and n is 9.

22. A process for preparing a compound of formula Ia:

the process comprises the steps of:

(a) reacting allylamine with 1-bromodecane to provide a compound of formula Va:

(b) reacting the compound of formula Va with 9-fluorenylmethyl chloroformate; to provide a compound of formula IIa:

(c) reacting the compound of formula IIa with ozone to form an ozonide intermediate;

(d) reacting the ozonide intermediate from step (c) with a reducing agent to form a compound of formula Ia.

23. The process according to claim 22 , wherein the reducing agent is a trialkylamine.

24. The process according to claim 23 , wherein the trialkylamine is triethylamine.

25. The product prepared by the process of any of claims 7 , 10 , 12 , or 22 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033180/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2003
From: LEE, JUNNING; LIU, JYANWEI
To: THERAVANCE, INC.
Reel/Frame 013936/0217 →